The COX-2 overexpression has been reported in several human cancers that include breast (23), lung (33), skin (34), esophagus (35), pancreas (36), prostate (37), bladder (38), stomach (39), oral cavity (40, 41), and colorectal adenocarcinoma (19, 42) (Table 1). Here, PTGS2 is linked to cancer.